Abstract

Malaria remains one of the world’s most devastating infectious diseases, caused by Plasmodium parasites and 
transmitted through Anopheles mosquitoes. Despite repeated exposure in endemic regions, the development of 
long-lasting immunity remains elusive due to complex host–parasite interactions, immune evasion mechanisms, 
and antigenic variation. This paper examines the multifaceted immunological responses to malaria, emphasizing 
how Plasmodium falciparum manipulates host immunity through antigenic variation, immune modulation, and 
persistence mechanisms that prevent sterilizing immunity. The roles of humoral and cellular immune responses, 
particularly memory B cells, T follicular helper (Tfh) cells, and tissue-resident memory T cells (Trm), are 
discussed in relation to their contribution to long-term protection. Global initiatives such as the Roll Back Malaria 
campaign, WHO’s Global Technical Strategy for Malaria (2016–2030), and community-based engagement efforts 
highlight the progress and challenges in malaria control and eradication. Advances in vaccine research, including 
whole-organism vaccines, recombinant platforms, and bispecific antibody therapies are reshaping prospects for 
immunological protection. However, ethical considerations concerning human challenge trials, gene-drive 
technology, and the management of G6PD deficiency remain critical in global malaria research. Understanding 
the molecular mechanisms underlying immune memory, immune evasion, and vaccine-induced immunity is pivotal 
to accelerating the development of next-generation vaccines and innovative therapeutics essential for malaria 
elimination and eventual eradication.